<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93-vaccines-07-00074">
 <label>93.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wagh</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Seaman</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Zingg</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fitzsimons</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Barouch</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Burton</surname>
    <given-names>D.R.</given-names>
   </name>
   <name>
    <surname>Connors</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ho</surname>
    <given-names>D.D.</given-names>
   </name>
   <name>
    <surname>Mascola</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Nussenzweig</surname>
    <given-names>M.C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Potential of conventional &amp; bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C &amp; D infections</article-title>
  <source>PLoS Pathog.</source>
  <year>2018</year>
  <volume>14</volume>
  <elocation-id>e1006860</elocation-id>
  <pub-id pub-id-type="pmid">29505593</pub-id>
 </element-citation>
</ref>
